Guardant Health, Inc.·4

Jul 2, 6:13 PM ET

Saia John G. 4

4 · Guardant Health, Inc. · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Guardant Health (GH) Chief Legal Officer John Saia Exercises RSUs

What Happened

  • John G. Saia, Chief Legal Officer of Guardant Health, had restricted stock units convert into 7,063 shares on July 1, 2026. The company withheld 3,707 shares to satisfy tax withholding at $170.77 per share (total value withheld: $633,044), leaving a net 3,356 shares delivered to Mr. Saia. This was a vesting/tax-withholding event, not an open-market sale.

Key Details

  • Transaction date: July 1, 2026; Form 4 filed July 2, 2026 (timely).
  • Acquired: 7,063 shares via exercise/conversion of RSUs (transaction code M).
  • Withheld/disposed for taxes: 3,707 shares at $170.77/share, value $633,044 (transaction code F; footnote F1 explains company retained shares to meet tax withholding).
  • Net shares retained by insider from this vesting: 3,356 (7,063 vested − 3,707 withheld).
  • Relevant awards: RSUs from grants on 11/7/2022, 12/13/2023, 11/8/2024, and 3/12/2025 with multi-year vesting schedules (see footnotes F2–F6).
  • Post-transaction total beneficial ownership not included in the provided excerpt.

Context

  • This was a routine RSU vesting with share withholding to cover taxes (common practice), not an open-market sale or purchase. Transaction codes: M = exercise/conversion of derivative (RSU vesting here), F = payment of tax liability via share withholding. Such withholding transactions generally reflect compensation tax mechanics rather than a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-07-01
Saia John G.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-07-01+97437,409 total
  • Exercise/Conversion

    Common Stock

    2026-07-01+1,66739,076 total
  • Exercise/Conversion

    Common Stock

    2026-07-01+2,92542,001 total
  • Exercise/Conversion

    Common Stock

    2026-07-01+1,49743,498 total
  • Tax Payment

    Common Stock

    [F1]
    2026-07-01$170.77/sh3,707$633,04439,791 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-07-01974974 total
    Exercise: $0.00Common Stock (974 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F4][F3]
    2026-07-011,6671,668 total
    Exercise: $0.00Common Stock (1,667 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F5][F3]
    2026-07-012,92514,626 total
    Exercise: $0.00Common Stock (2,925 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F3]
    2026-07-011,49710,474 total
    Exercise: $0.00Common Stock (1,497 underlying)
Footnotes (6)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F6]This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Signature
/s/ John G. Saia|2026-07-02

Documents

1 file
  • 4
    wk-form4_1783030399.xmlPrimary

    FORM 4